Compound Detail
CHEMBL202892
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL202892 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | UQKIMTZGDDFLIL-UHFFFAOYSA-N |
2
Targets
3
Activities
1
Assay Types
0
PK Parameters
16
Publications
0
Known Names
Molecular Properties
405.4
MW (Da)
2.82
ALogP
10
HBA
2
HBD
112.2
PSA (Ų)
0.48
QED
0
Ro5 Violations
7
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 3 meas. best 6.85
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Vascular endothelial growth factor receptor 2 CHEMBL279 | IC50 | 6.85 | 6.71 | 140.0 | 2 |
| Vascular endothelial growth factor receptor 1 CHEMBL1868 | IC50 | 6.36 | 6.36 | 440.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Vascular endothelial growth factor receptor 2 | IC50 | = | 140.0 | nM | 6.85 | Inhibition of VEGFR2 by enzymatic assay | 16321531 |
| Vascular endothelial growth factor receptor 2 | IC50 | = | 270.0 | nM | 6.57 | Inhibition of VEGFR2 in 293 adenovirus transfected kidney cells by cell-based EL... | 16321531 |
| Vascular endothelial growth factor receptor 1 | IC50 | = | 440.0 | nM | 6.36 | Inhibition of VEGFR1 by enzymatic assay | 16321531 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 16321531 | 10.1016/j.bmcl.2005.11.033 | Vascular endothelial growth factor receptor 2 | 2 |
| 16321531 | 10.1016/j.bmcl.2005.11.033 | Vascular endothelial growth factor receptor 1 | 1 |
| 16321531 | 10.1016/j.bmcl.2005.11.033 | Insulin-like growth factor 1 receptor | 1 |
| 16321531 | 10.1016/j.bmcl.2005.11.033 | Insulin receptor | 1 |
| 16321531 | 10.1016/j.bmcl.2005.11.033 | Fibroblast growth factor receptor 1 | 1 |
| 16321531 | 10.1016/j.bmcl.2005.11.033 | Receptor-type tyrosine-protein kinase FLT3 | 1 |
| 16321531 | 10.1016/j.bmcl.2005.11.033 | Epidermal growth factor receptor | 1 |
| 16321531 | 10.1016/j.bmcl.2005.11.033 | Receptor tyrosine-protein kinase erbB-2 | 1 |
| 16321531 | 10.1016/j.bmcl.2005.11.033 | Ephrin type-B receptor 4 | 1 |
| 16321531 | 10.1016/j.bmcl.2005.11.033 | Hepatocyte growth factor receptor | 1 |
| 16321531 | 10.1016/j.bmcl.2005.11.033 | cAMP-dependent protein kinase (PKA) | 1 |
| 16321531 | 10.1016/j.bmcl.2005.11.033 | Glycogen synthase kinase-3 beta | 1 |
| 16321531 | 10.1016/j.bmcl.2005.11.033 | RAC-alpha serine/threonine-protein kinase | 1 |
| 16321531 | 10.1016/j.bmcl.2005.11.033 | Bcr/Abl fusion protein | 1 |
| 16321531 | 10.1016/j.bmcl.2005.11.033 | Cyclin-dependent kinase 2 | 1 |
| 16321531 | 10.1016/j.bmcl.2005.11.033 | Cyclin-dependent kinase 5 | 1 |
Data from ChEMBL 36 via Core Engine